The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ctDNA mutational profiles in luminal breast cancer with early vs late distant relapse: Geicam/2014-03.
 
Angel Guerrero
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Novartis; Pfizer; Pierre Fabre
Research Funding - Lilly O.
Travel, Accommodations, Expenses - Gilead Sciences; Novartis; Pfizer
 
Isabel Alvarez
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Pfizer; Roche
Research Funding - AstraZeneca; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Eisai; Lilly O.; Pfizer; Roche
 
Ariadna Tibau
Honoraria - Lilly; Novartis
 
Josefina Cruz Jurado
Consulting or Advisory Role - AstraZeneca; Bayer; DAICHII; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; DAICHII; Gilead Sciences; Novartis; PharmaMar
 
César A Rodríguez Sánchez
No Relationships to Disclose
 
Purificacion Martinez
Consulting or Advisory Role - Leo Pharma; Lilly O.; Sanofi
Speakers' Bureau - AstraZeneca; Daiichi Sankyo Pharmaceutical; Leo Pharma; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Pharmaceutical; Leo Pharma; Pfizer; Roche
 
Catalina Falo
No Relationships to Disclose
 
Maria Hernández Sosa
No Relationships to Disclose
 
Mireia Margelí
Consulting or Advisory Role - Novartis; Pfizer; Pierre Fabre; Roche
Research Funding - AstraZeneca (Inst); Eisai (Inst); Kern Pharma (Inst); Roche (Inst)
 
Ana Miguel
No Relationships to Disclose
 
Jose Ignacio Chacon
Consulting or Advisory Role - AstraZeneca Spain; Daiichi Sankyo/Astra Zeneca; Eisai; Lilly; Merck; Novartis; Pfizer; Roche
 
Raquel Andres
No Relationships to Disclose
 
Encarna Adrover
Speakers' Bureau - AstraZeneca Spain; Lilly
 
Miguel Corbellas Aparicio
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Rosalia Caballero
No Relationships to Disclose
 
Jesus Herranz
No Relationships to Disclose
 
Daniel Fernández García
Employment - Almirall (I); Exonate (I)
Stock and Other Ownership Interests - AMADIX; Exonate (I)
Research Funding - Almirall (I); Exonate (I)
 
Silvia Antolín Novoa
Consulting or Advisory Role - Gilead Sciences
 
Sara López-Tarruella
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; GlaxoSmithKline; Lilly O.; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Seagen; Veracyte
 
Federico Rojo
Consulting or Advisory Role - Astellas Amgen BioPharama; Astellas Amgen BioPharama; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche
Research Funding - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; BMSi; MSD; Roche/Genentech